This compound is a pharmaceutical intermediate specifically designed for the synthesis of quinolone antibiotics. It features a complex tricyclic structure with difluoro substitution, an ester functionality, and an ether bridge, making it a key building block in the manufacture of this antibiotic class.
Область применения: Информация на этой странице относится к идентификации химических веществ и к контекстам промышленного снабжения, исследований и производства. Она не является терапевтическим заявлением, медицинской рекомендацией или инструкцией по применению лекарственных средств.
Закупаете или поставляете это соединение?
Разместите инвентарь или запрос на покупку
CAS 106939-34-8
Ethyl 9-fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-3,7-dihydro-2H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylate
Pharmaceutical intermediate for levofloxacin synthesis
9,10-Difluoro-2,3-dihydro-3-methyl-7-oxo-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid
fluoroquinolone antibiotic intermediate
Levofloxacin Q-Acid
Ofloxacin impurity reference standard
8,9-Difluoro-5-methyl-1-oxo-1,5,6,7-tetrahydropyrido[3,2,1-ij]quinoline-2-carboxylic acid
Pharmaceutical intermediate for quinolone antibiotics
7-CHLORO-1-CYCLOPROPYL-6-FLUORO-4-OXO-1,4-DIHYDRO-1,8-NAPHTHYRIDINE-3-CARBOXYLIC ACID
Pharmaceutical intermediate for quinolone antibiotics
N,N,N-Trimethyl-1-(6-methyl-2-(p-tolyl)imidazo[1,2-a]pyridin-3-yl)methanaminium iodide
Pharmaceutical impurity reference standard
5-Aza-2'-deoxy-6-oxo Cytidine
nucleoside analog intermediate
Tert-butyl N-[2-[2-[2-(2-hydroxyethoxy)ethoxy]ethoxy]ethyl]carbamate
PEGylated protective group intermediate
ethyl (2S)-6,7-difluoro-2-methyl-10-oxo-4-oxa-1-azatricyclo[7.3.1.05,13]trideca-5(13),6,8,11-tetraene-11-carboxylate
TZSXJUSNOOBBOP-ZETCQYMHSA-N
CCOC(=O)C1=CN2[C@H](COC3=C2C(=CC(=C3F)F)C1=O)C